NCT03352804

Brief Summary

Introduction : The multidrug resistance (MDR) Bacteriae are growing and are a public health problem. The known risk factors to be expanding of MDR Bacteriae are: taken antibiotics, hospitalization, journey in a country at risk. Other risk factors are emitted in hypothesis as the presence of pets. Aim : The primary objective is to study the association between the presence of a pet and the presence of a MDR bacteria. Methods : Cross sectional study will be performed in Reims University hospital in internal medicine ward.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2017

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2024

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

7 years

First QC Date

November 17, 2017

Last Update Submit

August 21, 2024

Conditions

Multidrug Resistance

Outcome Measures

Primary Outcomes (1)

  • Association between the presence of a pet and the presence of a MDR bacteria

    Day0

Study Arms (1)

Patients hospitalized in internal medicine ward

Patients included are patients hospitalized in internal medicine ward.

Other: Screening of MDR Bacteriae

Interventions

Screening of MDR BacteriaeOTHER

questionnaire will be filled by every patient

Patients hospitalized in internal medicine ward

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized in internal medicine ward of Reims University hospital

You may qualify if:

  • Patients who were screened for MDR bacteria
  • Patients who accepted to participate in the study
  • \>18yo

You may not qualify if:

  • Patient hospitalized before admission in our ward and having acquired a MDR bacteria in the course of care.
  • Patients coming from nursing home or institutionalized patients
  • Patient who cannot communicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Reims

Reims, 51092, France

Location

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2017

First Posted

November 24, 2017

Study Start

June 12, 2017

Primary Completion

June 11, 2024

Study Completion

August 21, 2024

Last Updated

August 22, 2024

Record last verified: 2024-08

Locations

FR(1)